Inventiva IVA
NASDAQ IVA
$3.69 +0.40 (+12.16%)
At close: Sep 30, 2026 · 4:00 PM EDT

Inventiva (IVA) Current Deferred Revenue (2018 - 2025)

Updated

Inventiva's Current Deferred Revenue was $1.19 million in Q2 2025, compared with $3,231 a year earlier.

Analysis

Inventiva (IVA) Current Deferred Revenue (2018 - 2025) Analysis & Trends

At the end of FY2023, Current Deferred Revenue at Inventiva came in at $6,456, up 5.5% from FY2022.

  • Current Deferred Revenue shows a five-year compound annual growth rate of -60.2% (FY2018 to FY2023).
  • In earlier years, Current Deferred Revenue was $6,121 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Inventiva 713.04 Mn 713.04 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 1.19 Mn
Jun 30, 2024 3,230.66
Dec 31, 2023 6,455.64
Jun 30, 2023 6,533.55
Dec 31, 2022 6,121.48
Jun 30, 2022 955,015.74
Dec 31, 2018 625,485.24
API Access

Inventiva Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=IVA&period=max&api_key=YOUR_API_KEY